2024 Q2 Form 10-Q Financial Statement
#000093454924000046 Filed on May 10, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $25.84M | $24.32M |
YoY Change | 226.9% | 64.29% |
Cost Of Revenue | $19.08M | $12.37M |
YoY Change | 113.35% | 24.17% |
Gross Profit | $6.758M | $11.96M |
YoY Change | -750.43% | 146.75% |
Gross Profit Margin | 26.16% | 49.16% |
Selling, General & Admin | $11.34M | $13.91M |
YoY Change | 0.47% | -0.32% |
% of Gross Profit | 167.77% | 116.34% |
Research & Development | $178.0K | $134.0K |
YoY Change | -13.17% | -37.96% |
% of Gross Profit | 2.63% | 1.12% |
Depreciation & Amortization | $7.405M | $4.568M |
YoY Change | 117.28% | 35.11% |
% of Gross Profit | 109.57% | 38.21% |
Operating Expenses | $11.52M | $14.04M |
YoY Change | 0.23% | -0.9% |
Operating Profit | -$4.758M | -$2.087M |
YoY Change | -62.02% | -77.62% |
Interest Expense | -$4.519M | $7.032M |
YoY Change | -42.76% | -66.91% |
% of Operating Profit | ||
Other Income/Expense, Net | -$11.13M | $789.0K |
YoY Change | 41.0% | -96.29% |
Pretax Income | -$15.89M | -$1.298M |
YoY Change | -22.2% | -110.88% |
Income Tax | -$7.061M | -$1.109M |
% Of Pretax Income | ||
Net Earnings | -$8.446M | -$186.0K |
YoY Change | -55.02% | -101.97% |
Net Earnings / Revenue | -32.69% | -0.76% |
Basic Earnings Per Share | -$0.08 | $0.00 |
Diluted Earnings Per Share | -$0.08 | $0.00 |
COMMON SHARES | ||
Basic Shares Outstanding | 100.0M shares | 99.90M shares |
Diluted Shares Outstanding | 100.1M shares | 99.75M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $441.9M | $498.4M |
YoY Change | -0.65% | 7.96% |
Cash & Equivalents | $387.0M | $438.8M |
Short-Term Investments | $54.92M | $59.67M |
Other Short-Term Assets | $20.96M | $29.47M |
YoY Change | 1.12% | 46.6% |
Inventory | $12.29M | $9.880M |
Prepaid Expenses | ||
Receivables | $18.77M | $15.37M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $493.9M | $553.1M |
YoY Change | 1.68% | 9.49% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $2.315M | $2.090M |
YoY Change | -21.53% | -36.18% |
Goodwill | $8.990M | $8.990M |
YoY Change | 19.21% | 19.21% |
Intangibles | $36.02M | $29.69M |
YoY Change | 17.74% | -11.7% |
Long-Term Investments | $30.93M | $30.93M |
YoY Change | 0.0% | 0.0% |
Other Assets | $4.257M | $4.572M |
YoY Change | -38.53% | -14.69% |
Total Long-Term Assets | $259.7M | $78.58M |
YoY Change | 430.83% | 52.84% |
TOTAL ASSETS | ||
Total Short-Term Assets | $493.9M | $553.1M |
Total Long-Term Assets | $259.7M | $78.58M |
Total Assets | $753.6M | $631.7M |
YoY Change | 40.94% | 13.5% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $3.191M | $4.702M |
YoY Change | -44.88% | -44.11% |
Accrued Expenses | $32.40M | $15.75M |
YoY Change | 259.08% | 0.4% |
Deferred Revenue | $911.0K | $1.069M |
YoY Change | -10.86% | -11.36% |
Short-Term Debt | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $44.20M | $25.85M |
YoY Change | -43.19% | -71.35% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $82.00M | $13.03M |
YoY Change | ||
Other Long-Term Liabilities | $1.479M | $1.417M |
YoY Change | -20.4% | -15.35% |
Total Long-Term Liabilities | $1.479M | $1.417M |
YoY Change | -20.4% | -15.35% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $44.20M | $25.85M |
Total Long-Term Liabilities | $1.479M | $1.417M |
Total Liabilities | $156.8M | $42.12M |
YoY Change | -10.94% | -76.53% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$248.4M | -$239.9M |
YoY Change | -21.43% | -19.31% |
Common Stock | $100.0K | $100.0K |
YoY Change | 72.41% | 72.41% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | $98.26M | $98.26M |
YoY Change | 0.0% | 0.0% |
Treasury Stock Shares | ||
Shareholders Equity | $560.7M | $568.3M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $753.6M | $631.7M |
YoY Change | 40.94% | 13.5% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$8.446M | -$186.0K |
YoY Change | -55.02% | -101.97% |
Depreciation, Depletion And Amortization | $7.405M | $4.568M |
YoY Change | 117.28% | 35.11% |
Cash From Operating Activities | $16.12M | $54.84M |
YoY Change | -209.09% | -1360.96% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $151.9M | $270.0K |
YoY Change | 281146.3% | 225.3% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | $42.31M |
YoY Change | -100.0% | 1376.27% |
Cash From Investing Activities | -$151.9M | $42.04M |
YoY Change | -2460.11% | 1410.6% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | $0.00 | |
YoY Change | -100.0% | |
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 84.05M | $1.826M |
YoY Change | -12589.45% | -97.66% |
NET CHANGE | ||
Cash From Operating Activities | 16.12M | $54.84M |
Cash From Investing Activities | -151.9M | $42.04M |
Cash From Financing Activities | 84.05M | $1.826M |
Net Change In Cash | -51.70M | $98.67M |
YoY Change | 473.78% | 29.08% |
FREE CASH FLOW | ||
Cash From Operating Activities | $16.12M | $54.84M |
Capital Expenditures | $151.9M | $270.0K |
Free Cash Flow | -$135.8M | $54.57M |
YoY Change | 815.61% | -1331.25% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | actg |
Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
|
3011000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1069000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
977000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
356000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
458000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2024#AccountsPayableAndOtherAccruedLiabilitiesCurrent | |
CY2023Q4 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2024#AccountsPayableAndOtherAccruedLiabilitiesCurrent | |
CY2024Q1 | us-gaap |
Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
|
http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent | |
CY2023Q4 | actg |
Royalties And Contingent Legal Fees Payable
RoyaltiesAndContingentLegalFeesPayable
|
10786000 | usd |
CY2024Q1 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
8450000 | usd |
CY2023Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
0 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
24320000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
14803000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
134000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
216000 | usd |
CY2024Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1555000 | usd |
CY2023Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1913000 | usd |
CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12353000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12040000 | usd |
CY2024Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
26407000 | usd |
CY2023Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
24127000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2087000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9324000 | usd |
CY2024Q1 | us-gaap |
Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
|
-26701000 | usd |
CY2023Q1 | us-gaap |
Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
|
3343000 | usd |
CY2024Q1 | us-gaap |
Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
|
28861000 | usd |
CY2023Q1 | us-gaap |
Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
|
-1361000 | usd |
CY2024Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
2160000 | usd |
CY2023Q1 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
1982000 | usd |
CY2024Q1 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
6243000 | usd |
CY2023Q1 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
0 | usd |
CY2024Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | usd |
CY2023Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
16651000 | usd |
CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-18000 | usd |
CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
80000 | usd |
CY2024Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
0 | usd |
CY2023Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
900000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
4890000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
3441000 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
789000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
21254000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1298000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
11930000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1109000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2483000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-189000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
9447000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-3000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-186000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
9447000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-186000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
5958000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99745905 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
47971931 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.12 | |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-186000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-6496000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
99745905 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
89067821 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
589609000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-189000 | usd |
CY2024Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
674000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
858000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
589604000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
269322000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
9447000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
|
1554000 | usd |
CY2023Q1 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
700000 | usd |
CY2023Q1 | actg |
Issuance Of Common Stock From The Rights Offering
IssuanceOfCommonStockFromTheRightsOffering
|
79111000 | usd |
CY2023Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
416000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
477000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
355687000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-189000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
9447000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4568000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3381000 | usd |
CY2024Q1 | actg |
Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
|
0 | usd |
CY2023Q1 | actg |
Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
|
5023000 | usd |
CY2024Q1 | actg |
Unrealized Gain Loss On Derivatives1
UnrealizedGainLossOnDerivatives1
|
0 | usd |
CY2023Q1 | actg |
Unrealized Gain Loss On Derivatives1
UnrealizedGainLossOnDerivatives1
|
11628000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
858000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
477000 | usd |
CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-18000 | usd |
CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
80000 | usd |
CY2024Q1 | us-gaap |
Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
|
-26701000 | usd |
CY2023Q1 | us-gaap |
Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
|
3343000 | usd |
CY2024Q1 | us-gaap |
Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
|
28861000 | usd |
CY2023Q1 | us-gaap |
Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
|
-1361000 | usd |
CY2024Q1 | actg |
Gain On Sale Of Prepaid Investment And Derivative
GainOnSaleOfPrepaidInvestmentAndDerivative
|
-629000 | usd |
CY2023Q1 | actg |
Gain On Sale Of Prepaid Investment And Derivative
GainOnSaleOfPrepaidInvestmentAndDerivative
|
0 | usd |
CY2024Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-3652000 | usd |
CY2023Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-240000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-65156000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
451000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-1041000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
503000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
10752000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
391000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
7108000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2355000 | usd |
CY2024Q1 | actg |
Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
|
-7811000 | usd |
CY2023Q1 | actg |
Increase Decrease In Royalties And Contingent Legal Fees Payable
IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
|
360000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
25000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-71000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
54839000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4349000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
15544000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
5166000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
|
57854000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
|
8032000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
270000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
83000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
42040000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2783000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
2500000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
0 | usd |
CY2024Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
0 | usd |
CY2023Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
700000 | usd |
CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
674000 | usd |
CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
416000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1826000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
77995000 | usd |
CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-34000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
98671000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
76441000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
340091000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
287786000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
438762000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
364227000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Interest
IncreaseDecreaseInPrepaidInterest
|
319000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Interest
IncreaseDecreaseInPrepaidInterest
|
0 | usd |
CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
116000 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
147000 | usd |
CY2024Q1 | actg |
Patent Acquisition Accrued Liability Long Term
PatentAcquisitionAccruedLiabilityLongTerm
|
-4000000 | usd |
CY2023Q1 | actg |
Patent Acquisition Accrued Liability Long Term
PatentAcquisitionAccruedLiabilityLongTerm
|
6000000 | usd |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
61123595 | shares |
CY2024Q1 | actg |
Number Of Patent Portfolios Acquired
NumberOfPatentPortfoliosAcquired
|
0 | patent |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
470000 | usd |
CY2023Q4 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
567000 | usd |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P2Y | |
CY2023Q4 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P2Y | |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.85 | |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.20 | |
CY2024Q1 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
757000 | usd |
CY2024Q1 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
19971000 | usd |
CY2024Q1 | us-gaap |
Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
|
2966000 | usd |
CY2024Q1 | us-gaap |
Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
|
19000 | usd |
CY2024Q1 | us-gaap |
Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
|
22918000 | usd |
CY2023Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
33423000 | usd |
CY2023Q1 | us-gaap |
Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
|
29680000 | usd |
CY2023Q1 | us-gaap |
Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
|
35000 | usd |
CY2023Q4 | us-gaap |
Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
|
63068000 | usd |
CY2024Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3404000 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3961000 | usd |
CY2024Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
1533000 | usd |
CY2023Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
1882000 | usd |
CY2024Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
5447000 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
5578000 | usd |
CY2024Q1 | us-gaap |
Inventory Gross
InventoryGross
|
10384000 | usd |
CY2023Q4 | us-gaap |
Inventory Gross
InventoryGross
|
11421000 | usd |
CY2024Q1 | us-gaap |
Inventory Adjustments
InventoryAdjustments
|
504000 | usd |
CY2023Q4 | us-gaap |
Inventory Adjustments
InventoryAdjustments
|
500000 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
9880000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
10921000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
4728000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
4760000 | usd |
CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2638000 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2404000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2090000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2356000 | usd |
CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
|
280000 | usd |
CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
|
347000 | usd |
CY2023Q1 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd |
CY2023Q1 | actg |
Accelerated Amortization Of Patents
AcceleratedAmortizationOfPatents
|
0 | usd |
CY2024Q1 | actg |
Accelerated Amortization Of Patents
AcceleratedAmortizationOfPatents
|
0 | usd |
CY2024Q1 | us-gaap |
Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
|
25533000 | usd |
CY2023Q4 | us-gaap |
Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
|
25276000 | usd |
CY2024Q1 | us-gaap |
Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
|
581000 | usd |
CY2023Q4 | us-gaap |
Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
|
159000 | usd |
CY2024Q1 | us-gaap |
Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
|
24952000 | usd |
CY2023Q4 | us-gaap |
Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
|
25117000 | usd |
CY2024Q1 | actg |
Oil And Gas Depreciation And Depletion Expense
OilAndGasDepreciationAndDepletionExpense
|
422000 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
8990000 | usd |
CY2024Q1 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
0 | usd |
CY2024Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
8990000 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
7541000 | usd |
CY2023 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
1449000 | usd |
CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
8990000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
353533000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
323843000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
29690000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
353533000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
319977000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
33556000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3900000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
3000000 | usd |
CY2024Q1 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
10964000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
12485000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
3173000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
1734000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
1334000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
29690000 | usd |
CY2024Q1 | actg |
Accrued Patent Investment Costs
AccruedPatentInvestmentCosts
|
15000000 | usd |
CY2023Q4 | actg |
Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
|
4000000 | usd |
CY2024Q1 | actg |
Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
|
0 | usd |
CY2023Q4 | actg |
Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
|
4000000 | usd |
CY2024Q1 | actg |
Accrued Consulting And Other Professional Fees
AccruedConsultingAndOtherProfessionalFees
|
832000 | usd |
CY2023Q4 | actg |
Accrued Consulting And Other Professional Fees
AccruedConsultingAndOtherProfessionalFees
|
1595000 | usd |
CY2024Q1 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
1313000 | usd |
CY2023Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
619000 | usd |
CY2024Q1 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
27000 | usd |
CY2023Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
30000 | usd |
CY2024Q1 | actg |
Service Contract Costs Accrued Current
ServiceContractCostsAccruedCurrent
|
168000 | usd |
CY2023Q4 | actg |
Service Contract Costs Accrued Current
ServiceContractCostsAccruedCurrent
|
169000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1094000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1248000 | usd |
CY2024Q1 | actg |
Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
|
0 | usd |
CY2023Q4 | actg |
Accrued Patent Investment Costs Current
AccruedPatentInvestmentCostsCurrent
|
4000000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
556000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
744000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
3990000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
8405000 | usd |
CY2023Q3 | actg |
Class Of Warrant Or Right Gross Proceeds Recapitalization Payment
ClassOfWarrantOrRightGrossProceedsRecapitalizationPayment
|
55000000 | usd |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
61123595 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
99886322 | shares |
CY2023Q3 | us-gaap |
Common Stock Dividends Shares
CommonStockDividendsShares
|
27704 | shares |
CY2023Q3 | actg |
Class Of Warrant Or Right Gross Proceeds Recapitalization Payment
ClassOfWarrantOrRightGrossProceedsRecapitalizationPayment
|
55000000 | usd |
CY2023Q3 | actg |
Class Of Warrant Or Right Recapitalization Payment
ClassOfWarrantOrRightRecapitalizationPayment
|
66000000 | usd |
CY2024Q1 | us-gaap |
Derivative Assets
DerivativeAssets
|
2100000 | usd |
CY2024Q1 | us-gaap |
Legal Fees
LegalFees
|
0 | usd |
CY2023Q1 | us-gaap |
Legal Fees
LegalFees
|
20000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
336000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
388000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
825000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
924000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
579000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
243000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
2571000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1094000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1477000 | usd |
CY2022Q3 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
40000000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P1Y | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | |
CY2024Q1 | actg |
Ownership Percent Of Voting Stock
OwnershipPercentOfVotingStock
|
0.10 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
1369000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
420000 | usd |
CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
4300000 | usd |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P1Y9M18D | |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-186000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
9447000 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
0 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
700000 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
|
0 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
|
1554000 | usd |
CY2024Q1 | us-gaap |
Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic
UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
|
0 | usd |
CY2023Q1 | us-gaap |
Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic
UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
|
1235000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-186000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
5958000 | usd |
CY2024Q1 | actg |
Dividend On Series A Redeemable Convertible Preferred Stock
DividendOnSeriesARedeemableConvertiblePreferredStock
|
0 | usd |
CY2023Q1 | actg |
Dividend On Series A Redeemable Convertible Preferred Stock
DividendOnSeriesARedeemableConvertiblePreferredStock
|
700000 | usd |
CY2024Q1 | actg |
Accretion Of Series A Redeemable Convertible Preferred Stock
AccretionOfSeriesARedeemableConvertiblePreferredStock
|
0 | usd |
CY2023Q1 | actg |
Accretion Of Series A Redeemable Convertible Preferred Stock
AccretionOfSeriesARedeemableConvertiblePreferredStock
|
1554000 | usd |
CY2024Q1 | actg |
Change In Fair Value Of Series A Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesARedeemableConvertiblePreferredStockEmbeddedDerivative
|
0 | usd |
CY2023Q1 | actg |
Change In Fair Value Of Series A Redeemable Convertible Preferred Stock Embedded Derivative
ChangeInFairValueOfSeriesARedeemableConvertiblePreferredStockEmbeddedDerivative
|
5023000 | usd |
CY2024Q1 | actg |
Change In Fair Value Of Dilutive Series B Warrants
ChangeInFairValueOfDilutiveSeriesBWarrants
|
0 | usd |
CY2023Q1 | actg |
Change In Fair Value Of Dilutive Series B Warrants
ChangeInFairValueOfDilutiveSeriesBWarrants
|
11628000 | usd |
CY2024Q1 | actg |
Interest Expense Associated With Starboard Notes Net Of Tax
InterestExpenseAssociatedWithStarboardNotesNetOfTax
|
0 | usd |
CY2023Q1 | actg |
Interest Expense Associated With Starboard Notes Net Of Tax
InterestExpenseAssociatedWithStarboardNotesNetOfTax
|
708000 | usd |
CY2024Q1 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
0 | usd |
CY2023Q1 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
1235000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-186000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-6496000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99745905 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
47971931 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
99745905 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
89067821 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.12 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | |
CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4231699 | shares |
CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2368870 | shares |
CY2024Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
3 | segment |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
24320000 | usd |
CY2024Q1 | us-gaap |
Royalty Expense
RoyaltyExpense
|
606000 | usd |
CY2024Q1 | actg |
Contingent Legal Fees
ContingentLegalFees
|
1824000 | usd |
CY2024Q1 | actg |
Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
|
1138000 | usd |
CY2024Q1 | actg |
Amortization Of Patents
AmortizationOfPatents
|
3433000 | usd |
CY2024Q1 | us-gaap |
Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
|
4049000 | usd |
CY2024Q1 | us-gaap |
Production Costs
ProductionCosts
|
1315000 | usd |
CY2024Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
12365000 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
11955000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2087000 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
789000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1298000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
14803000 | usd |
CY2023Q1 | us-gaap |
Royalty Expense
RoyaltyExpense
|
221000 | usd |
CY2023Q1 | actg |
Contingent Legal Fees
ContingentLegalFees
|
532000 | usd |
CY2023Q1 | actg |
Litigation And Licensing Expenses Patents
LitigationAndLicensingExpensesPatents
|
1384000 | usd |
CY2023Q1 | actg |
Amortization Of Patents
AmortizationOfPatents
|
2601000 | usd |
CY2023Q1 | us-gaap |
Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
|
5220000 | usd |
CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
9958000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
4845000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9324000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
21254000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
11930000 | usd |
CY2024Q1 | actg |
Trading Securities Fair Value Disclosure
TradingSecuritiesFairValueDisclosure
|
22918000 | usd |
CY2023Q4 | actg |
Trading Securities Fair Value Disclosure
TradingSecuritiesFairValueDisclosure
|
63068000 | usd |
CY2024Q1 | us-gaap |
Trading Securities Debt
TradingSecuritiesDebt
|
5816000 | usd |
CY2023Q4 | us-gaap |
Trading Securities Debt
TradingSecuritiesDebt
|
5816000 | usd |
CY2024Q1 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
30934000 | usd |
CY2023Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
30934000 | usd |
CY2024Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
59668000 | usd |
CY2023Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
99818000 | usd |
CY2024Q1 | us-gaap |
Other Assets
OtherAssets
|
261185000 | usd |
CY2023Q4 | us-gaap |
Other Assets
OtherAssets
|
218909000 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
631725000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
633545000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
24320000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
14803000 | usd |
CY2024Q1 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
27042000 | usd |
CY2023Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
27473000 | usd |